Summary
43 / 100 · Bulios Score
What speaks for it
- Revenue grew by 19% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
What to watch
- Earnings per share fell by 12% a year over the last 3 years.
- Earnings per share swing sharply from year to year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 18.9 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 14% a year over 5 years. Over the last 3 years it grew by 19% a year. Earnings per share fell by 12% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 28 USD
- Sales and administration 51 USD
- Taxes and other -4.6 USD
- Net profit 16 USD
Net profit, industry median (Banks - Regional) 21 USD
Out of every 100 USD of revenue, 16 USD is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 1.21%
- Paid out of profit
- 23%
You receive $0.36 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Neutral- Buy 2
- Hold 5
- Sell 0
Today's price within the analysts' price targets
The average target of $24.33 is 18% below today's price. 29% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2018By product
- Corporate LATAM 100%
By region
The company reports no revenue by region.
Corporate LATAM brings in 100% of revenue.
Segments in detail